Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Pediatr Res ; 74(4): 384-92, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23881110

ABSTRACT

BACKGROUND: Heterozygous ATP-binding-cassette subfamily A member 3 (ABCA3) mutations are associated with neonatal respiratory complications. In an adult murine model, we investigated whether Abca3 haploinsufficiency is a predisposing factor for lung injury induced by hyperoxia or mechanical ventilation. METHODS: Abca3 haploinsufficient (Abca3(+/-)) and wild-type (WT) mice were prospectively randomized to 25 min of ventilation or 72 h of hyperoxia or left unchallenged in air. RESULTS: As compared with WT mice, unchallenged Abca3(+/-) mice had significantly decreased lung phosphatidylcholine (PC) and phosphatidylglycerol (PG) levels (P < 0.02) and decreased lung compliance (P < 0.05). When ventilated for 25 min, Abca3(+/-) mice demonstrated a significantly greater increase in bronchoalveolar lavage (BAL) interleukins (P ≤ 0.01) and lung wet to dry ratio (P < 0.005). Hyperoxia resulted in increased compliance (P < 0.05) and total lung capacity (TLC) (P = 0.01) only in the Abca3(+/-) mice, consistent with enlarged alveolar spaces. The ratio of PC to PG in BAL-relevant for surfactant dysfunction-was significantly elevated by oxygen exposure, with the greatest increase in Abca3(+/-) mice. CONCLUSION: In a murine model, Abca3 haploinsufficiency results in an altered biochemical and lung mechanical phenotype, as well as a greater lung injury induced by hyperoxia or mechanical ventilation. The inability to maintain a normal PC/PG ratio appears to play a key role.


Subject(s)
ATP-Binding Cassette Transporters/genetics , Genetic Predisposition to Disease/genetics , Haploinsufficiency/genetics , Hyperoxia/complications , Respiration, Artificial/adverse effects , Respiratory Distress Syndrome/etiology , Analysis of Variance , Animals , Blotting, Western , Bronchoalveolar Lavage Fluid/chemistry , DNA Primers/genetics , Histological Techniques , Interleukins/analysis , Lung/metabolism , Lung/pathology , Lung Compliance/physiology , Mice , Phosphatidylcholines/analysis , Phosphatidylglycerols/analysis , Real-Time Polymerase Chain Reaction , Respiratory Distress Syndrome/genetics
2.
Nat Biotechnol ; 29(2): 154-7, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21217696

ABSTRACT

Current viral vectors for gene therapy are associated with serious safety concerns, including leukemogenesis, and nonviral vectors are limited by low gene transfer efficiency. Here we investigate the therapeutic utility of chemically modified mRNA as an alternative to DNA-based gene therapy. A combination of nucleotide modifications abrogates mRNA interaction with Toll-like receptor (TLR)3, TLR7, TLR8 and retinoid-inducible gene I (RIG-I), resulting in low immunogenicity and higher stability in mice. A single intramuscular injection of modified murine erythropoietin mRNA raises the average hematocrit in mice from 51.5% to 64.2% after 28 days. In a mouse model of a lethal congenital lung disease caused by a lack of surfactant protein B (SP-B), twice weekly local application of an aerosol of modified SP-B mRNA to the lung restored 71% of the wild-type SP-B expression, and treated mice survived until the predetermined end of the study after 28 days.


Subject(s)
Erythropoietin/biosynthesis , Gene Transfer Techniques , Proteolipids/biosynthesis , RNA, Messenger/administration & dosage , Animals , Erythropoietin/genetics , Histocytochemistry , Kaplan-Meier Estimate , Lung/metabolism , Mice , Mice, Transgenic , Proteolipids/genetics , RNA Stability , RNA, Messenger/chemistry , RNA, Messenger/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...